healthy adult men and women
Conditions
Interventions
None listed
Sponsors
Japan Clinical Trial Association
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants P:"Healthy adult men and women." Excludes individuals with diseases, minors, pregnant women, and breastfeeding women. Intervention I: "Oral intake of processed foods containing Hyperoside and Isoquercitrin derived from Apocynum venetum." Excludes cases where the amount of Hyperoside and Isoquercitrin derived from Apocynum venetum is not specified. Placebo C: "Oral intake of processed foods not containing Hyperoside and Isoquercitrin derived from Apocynum venetum." Excludes cases where the processed foods contain Hyperoside, Isoquercitrin, or other ingredients that clearly affect the outcomes. Outcome O: "Whether sleep quality improves." Objective evaluation includes sleep state measured by brain waves (such as the duration of REM sleep and non-REM sleep). Subjective evaluation includes questionnaires such as OSA-MA and VAS.
Exclusion criteria
Exclusion criteria: Exclude trials that do not meet the selection criteria, such as those including individuals with diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep state measured by brain waves (such as the duration of REM sleep and non-REM sleep), subjective evaluation (questionnaires such as OSA-MA,VAS) | — |
Countries
Japan
Contacts
Public ContactTakeshi Kaneko
Japan Clinical Trial Association N/A
Outcome results
None listed